![]() listing by a Chinese firm on record, after Alibaba Group Holding Ltd.’s $25 billion blockbuster debut in 2014. The oncology data platform will issue 10.8 million American depositary shares at a price range of USD17.50 to USD19.50, the Beijing-based firm said in its updated prospectus filed with. (Yicai Global) July 2 - China's LinkDoc Technology, a medical data company invested by Alibaba Group Holding's healthcare arm, aims to raise up to USD243 million in its initial public offering on the Nasdaq. The company said the proceeds of the IPO will be used to strengthen its research and development capabilities, investment, and acquisitions. Alibaba-Backed LinkDoc Eyes up to USD243 Million in Nasdaq IPO. It had filed in June 2021 to raise 200 million by offering 10.8 million ADSs at a price range of 17.50 to 19.50, but postponed in July. LinkDoc Technology Ltd, a medical data company backed by Alibabas health subsidiary, filed for an initial public offering in the US on Monday. LinkDoc, which is described as a Chinese medical data solutions provider, filed for an initial public offering (IPO) in the United States last month and was due to price its shares after the U.S. this year, according to data compiled by Bloomberg. ApLinkDoc Technology, a Chinese healthcare data company specializing in oncology patients, withdrew its plans for an initial public offering on Monday. Its investors include Alibaba Health Information Technology Ltd., MBK Partners, New Enterprise Associates and Temasek Holdings Pte according to a preliminary filing.Ĭhinese companies have raised about $13 billion through first-time share sales in the U.S. LinkDoc, founded in 2014, provides cancer focused health-care services built on big data and artificial intelligence, its website shows. A representative for LinkDoc declined to comment. Backed by Alibaba Health Information Technology Ltd, LinkDoc filed for its IPO last month and was due to price its shares after the U.S. IPO, nine months after its 11th hour halt to the listing. On July 1, 2021, LinkDoc updated its IPO prospectus after it was first filed in June of the same year. LinkDoc has formally withdrawn its plan to raise 200 million from a U.S. ![]() ![]() Reuters reported LinkDoc’s IPO halt earlier Thursday. LinkDoc Technology recently withdrew its IPO application in the US market after a nine-month halt to the process. LinkDoc’s IPO delay also comes as regulators in Beijing are planning rule changes that would allow them to block a Chinese company from listing overseas even if the unit selling shares is incorporated outside China, closing a loophole long-used by the country’s technology giants, Bloomberg News reported this week.
0 Comments
Leave a Reply. |